支架内新生动脉粥样硬化斑块研究进展(4)
[11] Habara M， Terashima M， Nasu K， et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation： an optical coherence tomography study[J]. Circ Cardiovasc Interv，2011，4(3)：232-238.
[12] Kitabata H， Tanaka A， Kubo T， et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease[J]. Am J Cardiol，2010，105(12)：1673-1678.
, http://www.100md.com
[13] Kang S J， Mintz G S， Park D W， et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis[J]. Am J Cardiol，2010，106(11)：1561-1565.
[14] Kimura T， Abe K， Shizuta S， et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries[J]. Circulation，2002，105(25)：2986-2991.
[15] Takano M， Yamamoto M， Inami S， et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography[J]. J Am Coll Cardiol，2009，55(1)：26-32.
, 百拇医药
[16] Otsuka F， Vorpahl M， Nakano M， et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans[J]. Circulation，2014，129(2)：211-223.
[17] Natsuaki M， Morimoto T， Furukawa Y， et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent long-term (5–7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2[J]. Circ Cardiovasc Interv，2014，7(2)：168-179.
, http://www.100md.com
[18] Tian J， Ren X， Uemura S， et al. Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics： optical coherence tomography study[J]. Am Heart J，2014，167(6)：884-892.
[19] Vergallo R， Yonetsu T， Uemura S， et al. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography[J]. Am J Cardiol，2013，112(9)：1315-1321.
, 百拇医药
[20] Macneill B D， Jang I K， Bouma B E， et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease[J]. J Am Coll Cardiol，2004，44(5)：972-979.
[21] Stone G W， Maehara A， Lansky A J， et al. A prospective natural-history study of coronary atherosclerosis[J]. N Engl J Med，2011，364(3)：226-235.
[22] Amabile N， Souteyrand G， Ghostine S， et al. Very late stent thrombosis related to incomplete neointimal coverage or neoatherosclerotic plaque rupture identified by optical coherence tomography imaging[J]. Eur Heart J Cardiovasc Imaging，2014，15(1)：24-31.
[23] Ali Z A， Roleder T， Narula J， et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis： multimodality intravascular imaging of drug-eluting and bare-metal stents[J]. Circ Cardiovasc Interv，2013，6(5)：507-517.
(收稿日期：2015-07-13) (本文编辑：王宇), http://www.100md.com(邓婵翠 石蓓 刘志江)
[12] Kitabata H， Tanaka A， Kubo T， et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease[J]. Am J Cardiol，2010，105(12)：1673-1678.
, http://www.100md.com
[13] Kang S J， Mintz G S， Park D W， et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis[J]. Am J Cardiol，2010，106(11)：1561-1565.
[14] Kimura T， Abe K， Shizuta S， et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries[J]. Circulation，2002，105(25)：2986-2991.
[15] Takano M， Yamamoto M， Inami S， et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography[J]. J Am Coll Cardiol，2009，55(1)：26-32.
, 百拇医药
[16] Otsuka F， Vorpahl M， Nakano M， et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans[J]. Circulation，2014，129(2)：211-223.
[17] Natsuaki M， Morimoto T， Furukawa Y， et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent long-term (5–7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2[J]. Circ Cardiovasc Interv，2014，7(2)：168-179.
, http://www.100md.com
[18] Tian J， Ren X， Uemura S， et al. Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics： optical coherence tomography study[J]. Am Heart J，2014，167(6)：884-892.
[19] Vergallo R， Yonetsu T， Uemura S， et al. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography[J]. Am J Cardiol，2013，112(9)：1315-1321.
, 百拇医药
[20] Macneill B D， Jang I K， Bouma B E， et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease[J]. J Am Coll Cardiol，2004，44(5)：972-979.
[21] Stone G W， Maehara A， Lansky A J， et al. A prospective natural-history study of coronary atherosclerosis[J]. N Engl J Med，2011，364(3)：226-235.
[22] Amabile N， Souteyrand G， Ghostine S， et al. Very late stent thrombosis related to incomplete neointimal coverage or neoatherosclerotic plaque rupture identified by optical coherence tomography imaging[J]. Eur Heart J Cardiovasc Imaging，2014，15(1)：24-31.
[23] Ali Z A， Roleder T， Narula J， et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis： multimodality intravascular imaging of drug-eluting and bare-metal stents[J]. Circ Cardiovasc Interv，2013，6(5)：507-517.
(收稿日期：2015-07-13) (本文编辑：王宇), http://www.100md.com(邓婵翠 石蓓 刘志江)